Vitamin Shoppe (VSI) 10-Q 2 Nov 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 24, 2016	Oct. 14, 2016
Document And Entity Information [Abstract]
Entity Registrant Name	Vitamin Shoppe, Inc.
Entity Central Index Key	1,360,530
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 24, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		23,816,518

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 24, 2016	Dec. 26, 2015
Current assets:
Cash and cash equivalents	$ 2,023	$ 15,104
Accounts receivable, net of allowance of $1,163 and $897 in 2016 and 2015, respectively	6,958	7,437
Inventories	223,672	226,830
Prepaid expenses and other current assets	29,602	25,194
Total current assets	262,255	274,565
Property and equipment, net of accumulated depreciation and amortization of $297,016 and $274,222 in 2016 and 2015, respectively	140,492	140,158
Goodwill	243,269	243,269
Other intangibles, net	86,314	87,270
Other assets	4,187	3,429
Total assets	736,517	748,691
Current liabilities:
Revolving credit facility	6,000	8,000
Accounts payable	50,911	41,217
Accrued expenses and other current liabilities	60,137	68,259
Total current liabilities	117,048	117,476
Convertible notes, net	119,413	115,410
Deferred rent	38,387	39,889
Other long-term liabilities	1,876	615
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value; 250,000,000 shares authorized and no shares issued and outstanding at September 24, 2016 and December 26, 2015	0	0
Common stock, $0.01 par value; 400,000,000 shares authorized, 23,970,736 shares issued and 23,810,726 shares outstanding at September 24, 2016, and 25,993,715 shares issued and 25,873,581 shares outstanding at December 26, 2015	240	260
Additional paid-in capital	88,876	139,827
Treasury stock, at cost; 160,010 shares at September 24, 2016 and 120,134 shares at December 26, 2015	(6,400)	(5,225)
Accumulated other comprehensive loss	0	(60)
Retained earnings	377,077	340,499
Total stockholders’ equity	459,793	475,301
Total liabilities and stockholders’ equity	$ 736,517	$ 748,691

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 24, 2016	Dec. 26, 2015
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 1,163	$ 897
Accumulated depreciation and amortization, property and equipment	$ 297,016	$ 274,222
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	250,000,000	250,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	23,970,736	25,993,715
Common stock, shares outstanding (in shares)	23,810,726	25,873,581
Treasury stock, shares (in shares)	160,010	120,134

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 24, 2016	Sep. 26, 2015	Sep. 24, 2016	Sep. 26, 2015
Income Statement [Abstract]
Net sales	$ 314,887	$ 313,886	$ 984,378	$ 973,059
Cost of goods sold	212,762	209,177	658,182	645,441
Gross profit	102,125	104,709	326,196	327,618
Selling, general and administrative expenses	81,852	81,352	257,937	249,742
Income from operations	20,273	23,357	68,259	77,876
Interest expense, net	2,363	172	6,977	515
Income before provision for income taxes	17,910	23,185	61,282	77,361
Provision for income taxes	6,547	9,087	24,704	30,322
Net income	$ 11,363	$ 14,098	$ 36,578	$ 47,039
Weighted average common shares outstanding
Basic (in shares)	23,578,334	28,988,779	24,048,201	29,238,808
Diluted (in shares)	23,769,726	29,190,454	24,239,254	29,504,418
Net income per common share
Basic (in dollars per share)	$ 0.48	$ 0.49	$ 1.52	$ 1.61
Diluted (in dollars per share)	$ 0.48	$ 0.48	$ 1.51	$ 1.59

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 24, 2016	Sep. 26, 2015	Sep. 24, 2016	Sep. 26, 2015
Statement of Comprehensive Income [Abstract]
Net income	$ 11,363	$ 14,098	$ 36,578	$ 47,039
Other comprehensive income (loss):
Foreign currency translation adjustments	0	(85)	60	(26)
Other comprehensive income (loss)	0	(85)	60	(26)
Comprehensive income	$ 11,363	$ 14,013	$ 36,638	$ 47,013

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 24, 2016	Sep. 26, 2015
Cash flows from operating activities:
Net income	$ 36,578	$ 47,039
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of fixed and intangible assets	28,812	28,457
Impairment charges on fixed assets	415	321
Amortization of deferred financing fees	708	141
Amortization of debt discount on convertible notes	3,434	0
Deferred income taxes	1,309	3,248
Deferred rent	(2,340)	(1,708)
Equity compensation expense	4,706	4,716
Issuance of shares for services rendered	333	0
Tax benefits on exercises of equity awards	714	71
Contingent consideration for acquisition of FDC Vitamins, LLC	0	(959)
Changes in operating assets and liabilities:
Accounts receivable	479	5,311
Inventories	4,506	(29,911)
Prepaid expenses and other current assets	(4,407)	(786)
Other long-term assets	106	(221)
Accounts payable	11,337	1,292
Accrued expenses and other current liabilities	(9,442)	(3,087)
Other long-term liabilities	840	2,726
Net cash provided by operating activities	78,088	56,650
Cash flows from investing activities:
Capital expenditures	(31,228)	(30,172)
Acquisition of FDC Vitamins, LLC	0	487
Trademarks and other intangible assets	(221)	(444)
Net cash used in investing activities	(31,449)	(30,129)
Cash flows from financing activities:
Borrowings under revolving credit facility	51,000	27,000
Repayments of borrowings under revolving credit facility	(53,000)	(27,000)
Bank overdraft	(377)	5,822
Contingent consideration payment for acquisition of FDC Vitamins, LLC	0	(4,041)
Proceeds from exercises of common stock options	90	1,348
Issuance of shares under employee stock purchase plan	536	718
Tax benefits on exercises of equity awards	(714)	(71)
Purchases of treasury stock	(1,175)	(2,492)
Purchases of shares under Share Repurchase Programs	(56,011)	(37,965)
Other financing activities	(125)	(97)
Net cash used in financing activities	(59,776)	(36,778)
Effect of exchange rate changes on cash and cash equivalents	56	72
Net decrease in cash and cash equivalents	(13,081)	(10,185)
Cash and cash equivalents beginning of period	15,104	12,166
Cash and cash equivalents end of period	2,023	1,981
Supplemental disclosures of cash flow information:
Interest paid	1,879	282
Income taxes paid	30,968	26,351
Supplemental disclosures of non-cash investing activities:
Liability for purchases of property and equipment	4,327	5,617
Assets acquired under capital leases	$ 1,589	$ 0

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 24, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Vitamin Shoppe, Inc. (“ VSI ”), is incorporated in the State of Delaware, and through its wholly-owned subsidiary, Vitamin Shoppe Industries Inc. (“Subsidiary” or “Industries” together with VSI, the “Company”), is a multi-channel specialty retailer and contract manufacturer of nutritional products. Sales of both national brands and our own brands of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products (“VMS products”) are made through VSI-operated retail stores and the internet to customers located primarily in the United States. The Company manufactures products for both sales to third parties as well as for the VSI product assortment. The condensed consolidated financial statements as of September 24, 2016 and September 26, 2015 are unaudited. The condensed consolidated balance sheet as of December 26, 2015 was derived from our audited financial statements. All intercompany transactions and balances have been eliminated in consolidation. In addition, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted. The interim financial statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation in conformity with GAAP. The interim financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K for the fiscal year ended December 26, 2015 , as filed with the Securities and Exchange Commission on February 23, 2016 (the “Fiscal 2015 Form 10-K”). The results of operations for the interim periods should not be considered indicative of results to be expected for the full year. The Company's fiscal year ends on the last Saturday in December. As used herein, the term "Fiscal Year" or "Fiscal" refers to a 52-week or 53-week period, ending on the last Saturday in December. Fiscal 2016 is a 53-week fiscal year. The results for the three and nine months ended September 24, 2016 and September 26, 2015 are each based on 13-week and 39-week periods, respectively. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements, and revenue and expenses during the reporting period. Actual results could differ from those estimates. Except as noted below, the Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on its results of operations, financial condition, or cash flows, based on current information. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09 (“ASU 2014-09”), Revenue from Contracts with Customers (Topic 606). Under ASU 2014-09, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of ASU 2014-09 by one year. ASU 2014-09 will be effective for annual reporting periods beginning after December 15, 2017 for public companies and early adoption of ASU 2014-09 is permitted for public companies for annual reporting periods beginning after December 15, 2016. The Company is evaluating ASU 2014-09 to determine which transition approach it will utilize and if this guidance will have a material impact on the Company’s condensed consolidated financial statements. In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (“ASU 2016-02”), Leases (Topic 842). ASU 2016-02 was issued by the FASB to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. ASU 2016-02 will require modified retrospective application at the beginning of our first quarter of Fiscal 2019, but permits adoption in an earlier period. The Company is evaluating ASU 2016-02 in order to determine the impact of this guidance on the Company’s condensed consolidated financial statements and anticipates this guidance will result in a significant increase to long-term assets and liabilities given we have a significant number of leases. In March 2016, the FASB issued Accounting Standards Update No. 2016-09 (“ASU 2016-09”), Compensation-Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 addresses simplification of several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for public companies for annual reporting periods beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption of ASU 2016-09 is permitted. The Company has evaluated ASU 2016-09 and does not expect the impact of this guidance to have a material impact on the Company's condensed consolidated financial statements. However, under certain circumstances, this guidance could have an impact on the Company’s effective tax rate as changes between tax and book treatment of equity compensation will be recognized in the provision for income taxes beginning in Fiscal 2017.

Inventories

Inventories	9 Months Ended
	Sep. 24, 2016
Inventory Disclosure [Abstract]
Inventories	Inventories The components of inventories are as follows (in thousands): September 24, 2016 December 26, 2015 Finished goods $ 202,202 $ 211,879 Work-in-process 5,016 6,180 Raw materials 16,454 8,771 $ 223,672 $ 226,830

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 24, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is allocated between the Company’s segments (reporting units), retail, direct and manufacturing. The following table discloses the carrying value of all intangible assets (in thousands): September 24, 2016 December 26, 2015 Gross Carrying Amount Accumulated Amortization Net Gross Carrying Amount Accumulated Amortization Net Intangible assets Goodwill $ 243,269 $ — $ 243,269 $ 243,269 $ — $ 243,269 Tradenames – Indefinite-lived 68,405 — 68,405 68,405 — 68,405 Brands 10,000 1,296 8,704 10,000 880 9,120 Customer relationships 7,500 875 6,625 7,500 594 6,906 Tradenames – Definite-lived 4,894 3,007 1,887 4,673 2,722 1,951 Software 1,300 607 693 1,300 412 888 $ 335,368 $ 5,785 $ 329,583 $ 335,147 $ 4,608 $ 330,539 The useful lives of the Company’s definite-lived intangible assets are between 3 to 20 years. The expected amortization expense on definite-lived intangible assets on the Company’s condensed consolidated balance sheet at September 24, 2016 , is as follows (in thousands): Remainder of Fiscal 2016 $ 355 Fiscal 2017 1,435 Fiscal 2018 1,435 Fiscal 2019 1,435 Fiscal 2020 1,435 Thereafter 11,814 $ 17,909

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Sep. 24, 2016
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following (in thousands): September 24, 2016 December 26, 2015 Accrued salaries and related expenses $ 14,124 $ 10,115 Sales tax payable and related expenses 7,777 6,975 Deferred sales (a) 5,413 20,483 Accrued fixed asset additions 3,935 5,842 Other accrued expenses 28,888 24,844 $ 60,137 $ 68,259 (a) The reduction in deferred sales reflects the change in the Company's loyalty program from annual redemptions to quarterly redemptions beginning in Fiscal 2016.

Credit Arrangements

Credit Arrangements	9 Months Ended
	Sep. 24, 2016
Debt Disclosure [Abstract]
Credit Arrangements	Credit Arrangements Convertible Senior Notes due 2020 On December 9, 2015, the Company issued $143.8 million of its 2.25% Convertible Senior Notes due 2020 (the “Convertible Notes”). The Convertible Notes are senior unsecured obligations of VSI. Interest on the Convertible Notes is payable on June 1 and December 1 of each year, commencing on June 1, 2016 until their maturity date of December 1, 2020. The Company may not redeem the Convertible Notes prior to the maturity date. Prior to July 1, 2020, the Convertible Notes will be convertible only under certain circumstances. The Convertible Notes will be convertible at an initial conversion rate of 25.1625 shares of the Company’s common stock per $1,000 principal amount of the Convertible Notes, which is equivalent to an initial conversion price of approximately $39.74 . The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date, the Company is required to increase, in certain circumstances, the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event including customary conversion rate adjustments in connection with a “make-whole fundamental change” as defined. Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at its election. The Company allocated the principal amount of the Convertible Notes between its liability and equity components (see table below). The carrying amount of the liability component was determined by measuring the fair value of a similar debt instrument of similar credit quality and maturity that did not have the conversion feature. The carrying amount of the equity component, representing the embedded conversion option, was determined by deducting the fair value of the liability component from the principal amount of the Convertible Notes as a whole. The equity component was recorded to additional paid-in capital and is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the Convertible Notes over the carrying amount of the liability component was recorded as a debt discount, and is being amortized to interest expense using an effective interest rate of 3.8% over the term of the Convertible Notes. The Company allocated the total amount of transaction costs incurred to the liability and equity components using the same proportions as the proceeds from the Convertible Notes. Transaction costs attributable to the liability component were recorded as a direct deduction from the liability component of the Convertible Notes, and are being amortized to interest expense using the effective interest method through the maturity date. Transaction costs attributable to the equity component were netted with the equity component of the Convertible Notes in additional paid-in capital. The Convertible Notes consist of the following components (in thousands): September 24, 2016 December 26, 2015 Liability component: Principal $ 143,750 $ 143,750 Conversion feature (24,800 ) (24,800 ) Liability portion of debt issuance costs (3,802 ) (3,800 ) Amortization 4,265 260 Net carrying amount $ 119,413 $ 115,410 Equity component: Conversion feature $ 24,800 $ 24,800 Equity portion of debt issuance costs (793 ) (793 ) Deferred taxes 941 941 Net carrying amount $ 24,948 $ 24,948 In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge transactions for which it paid an aggregate $26.4 million . In addition, the Company sold warrants for which it received aggregate proceeds of $13.0 million . The convertible note hedge transactions are expected generally to reduce potential dilution of the Company’s common stock upon any conversion of notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted notes. However, the warrant transaction could separately have a dilutive effect to the extent that the market value per share of the Company’s common stock exceeds the applicable strike price of the warrant transactions, which is approximately $52.99 at inception. As these transactions meet certain accounting criteria, the convertible note hedge and warrant transactions are recorded in stockholders’ equity, are not accounted for as derivatives and are not remeasured each reporting period. The net proceeds from the Convertible Notes and related transactions of $125.7 million , net of commissions and offering costs of $4.6 million , were used to repurchase shares of the Company’s common stock under the Company’s share repurchase programs. Refer to Note 9. Share Repurchase Programs for additional information. Revolving Credit Facility As of September 24, 2016 and December 26, 2015 , the Company had $6.0 million and $8.0 million of borrowings outstanding on its Revolving Credit Facility (the "Revolving Credit Facility"), respectively. Subject to the terms of the Revolving Credit Facility, which has a maturity date of October 11, 2018 , the Company may borrow up to $90.0 million , with a Company option to increase the facility up to a total of $150.0 million . The availability under the Revolving Credit Facility is subject to a borrowing base calculated on the value of certain accounts receivable as well as certain inventory of the Company. The obligations thereunder are secured by a security interest in substantially all of the assets of the Company. Under the Revolving Credit Facility, VSI has guaranteed the Company’s obligations, and Industries and its wholly-owned subsidiaries have each guaranteed the obligations of the other respective entities. The Revolving Credit Facility provides for affirmative and negative covenants affecting the Company. The Revolving Credit Facility restricts, among other things, the Company’s ability to incur indebtedness, create or permit liens on the Company’s assets, declare or pay dividends and make certain other restricted payments, consolidate, merge or recapitalize, sell assets, make certain investments, loans or other advances, enter into transactions with affiliates, change our line of business, and restricts the types of hedging activities the Company can enter into. The largest amount outstanding during both the nine months ended September 24, 2016 and September 26, 2015 was $27.0 million . The unused available line of credit under the Revolving Credit Facility at September 24, 2016 was $81.1 million . Borrowings under the Revolving Credit Facility accrue interest, at the Company’s option, at the rate per annum based on an “alternative base rate” plus 0.25% or 0.50% or the adjusted Eurodollar rate plus 1.25% or 1.50% , in each case with the higher spread applicable in the event that the aggregate amount of the borrowings under the Revolving Credit Facility exceeds 50% of the borrowing base availability under the Revolving Credit Facility. The weighted average interest rate for the Revolving Credit Facility during the nine months ended September 24, 2016 and September 26, 2015 was 1.75% and 1.44% , respectively. The commitment fee on the undrawn portion of the $90.0 million Revolving Credit Facility was 0.25% as of September 24, 2016 and December 26, 2015 . Interest expense, net for the three and nine months ended September 24, 2016 and September 26, 2015 consists of the following (in thousands): Three Months Ended Nine Months Ended September 24, 2016 September 26, 2015 September 24, 2016 September 26, 2015 Amortization of debt discount on convertible notes $ 1,156 $ — $ 3,434 $ — Interest on convertible notes 818 — 2,455 — Amortization of deferred financing fees 236 62 708 141 Interest / fees on the revolving credit facility and other interest 153 110 380 375 Interest income — — — (1 ) Interest expense, net $ 2,363 $ 172 $ 6,977 $ 515

Stock Based Compensation

Stock Based Compensation	9 Months Ended
	Sep. 24, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Based Compensation	Stock Based Compensation Equity Incentive Plans – The Company has two equity incentive plans that provide stock based compensation to certain directors, officers, consultants and employees of the Company; the 2006 Stock Option Plan (the “2006 Plan”) and the Vitamin Shoppe 2009 Equity Incentive Plan, as amended and restated effective April 6, 2012, (the “2009 Plan”). As of September 24, 2016 , there were 2,077,482 shares available to grant under both plans which includes 160,010 shares currently held by the Company as treasury stock. The following table summarizes restricted shares for the 2009 Plan as of September 24, 2016 and changes during the nine month period then ended: Number of Unvested Restricted Shares Weighted Average Grant Date Fair Value Unvested at December 26, 2015 398,562 $ 42.65 Granted 165,605 $ 30.04 Vested (101,009 ) $ 46.72 Canceled/forfeited (84,031 ) $ 43.35 Unvested at September 24, 2016 379,127 $ 35.90 The total intrinsic value of restricted shares vested during the nine months ended September 24, 2016 and September 26, 2015 , was $2.7 million and $6.2 million , respectively. The following table summarizes stock options for the 2006 and 2009 Plans as of September 24, 2016 and changes during the nine month period then ended: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life (years) Aggregate Intrinsic Value (in thousands) Outstanding at December 26, 2015 284,838 $ 22.65 Granted 233,285 $ 30.03 Exercised (5,282 ) $ 17.11 Canceled/forfeited (30,155 ) $ 32.66 Outstanding at September 24, 2016 482,686 $ 25.65 5.38 $ 2,022 Vested or expected to vest at September 24, 2016 467,286 $ 25.65 5.38 Vested and exercisable at September 24, 2016 261,449 $ 21.95 1.89 $ 2,020 The total intrinsic value of options exercised during the nine months ended September 24, 2016 was $0.1 million and during the nine months ended September 26, 2015 was $1.0 million . The cash received from options exercised during the nine months ended September 24, 2016 was $0.1 million and during the nine months ended September 26, 2015 was $1.3 million . Stock options granted during the nine months ended September 24, 2016 shall become vested in equal installments on the first, second and third anniversaries of the date on which such equity grants were awarded. The following table summarizes performance share units for the 2009 Plan as of September 24, 2016 and changes during the nine month period then ended: Number of Unvested Performance Share Units Weighted Average Grant Date Fair Value Unvested at December 26, 2015 — $ — Granted 134,927 $ 30.42 Vested — $ — Canceled/forfeited (6,608 ) $ 30.26 Unvested at September 24, 2016 128,319 $ 30.43 Performance share units granted during the nine months ended September 24, 2016 shall become vested on December 29, 2018 if the performance criteria are achieved. Performance share units can vest at a range of 25% to 150% based on the achievement of pre-established performance targets. The following table summarizes restricted share units for the 2009 Plan as of September 24, 2016 and changes during the nine month period then ended: Number of Unvested Weighted Unvested at December 26, 2015 11,280 $ 37.25 Granted 21,451 $ 30.68 Vested (12,220 ) $ 36.69 Canceled/forfeited — $ — Unvested at September 24, 2016 20,511 $ 30.71 The total intrinsic value of restricted share units vested during the nine months ended September 24, 2016 and September 26, 2015 , was $0.3 million and $0.5 million , respectively. Compensation expense attributable to stock based compensation for the three and nine months ended September 24, 2016 was approximately $1.2 million and $4.7 million , respectively, and for the three and nine months ended September 26, 2015 was approximately $1.2 million and $4.7 million , respectively. As of September 24, 2016 , the remaining unrecognized stock based compensation expense for non-vested stock options, restricted shares, performance share units and restricted share units to be expensed in future periods is $8.9 million , and the related weighted-average period over which it is expected to be recognized is 1.8 years. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company estimates forfeitures based on its historical forfeiture rate since the inception of granting stock based awards. The estimated value of future forfeitures for stock options, restricted shares, performance share units and restricted share units as of September 24, 2016 is approximately $0.7 million . The weighted-average grant date fair value of stock options during the three and nine months ended September 24, 2016 was $7.07 and $8.21 , respectively. Stock options were not granted during the three and nine months ended September 26, 2015 . The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions: Three Months Ended Nine Months Ended September 24, 2016 September 24, 2016 Expected dividend yield 0.0 % 0.0 % Weighted average expected volatility 31.4 % 32.5 % Weighted average risk-free interest rate 1.0 % 1.2 % Expected holding period 4.00 years 4.00 years Treasury Stock – As part of the Company’s equity incentive plans, the Company makes required tax payments on behalf of employees as their restricted shares vest. The Company withholds the number of vested shares having a value on the date of vesting equal to the minimum statutory tax obligation. The shares withheld are recorded as treasury shares. During the nine months ended September 24, 2016 , the Company purchased 39,876 shares in settlement of employees’ tax obligations for a total of $1.2 million . The Company accounts for treasury stock using the cost method. These shares are available to grant under the Company’s equity incentive plans.

Advertising Costs

Advertising Costs	9 Months Ended
	Sep. 24, 2016
Other Income and Expenses [Abstract]
Advertising Costs	Advertising Costs The costs of advertising for online marketing arrangements, magazines, direct mail and radio are primarily expensed the first time the advertising takes place. Advertising expense was $5.7 million and $5.3 million for the three months ended September 24, 2016 and September 26, 2015 , respectively, and $18.1 million and $16.8 million for the nine months ended September 24, 2016 and September 26, 2015 , respectively.

Net Income Per Share

Net Income Per Share	9 Months Ended
	Sep. 24, 2016
Earnings Per Share [Abstract]
Net Income Per Share	Net Income Per Share The Company’s basic net income per share excludes the dilutive effect of stock options, unvested restricted shares, unvested performance share units and unvested restricted share units. It is based upon the weighted average number of common shares outstanding during the period divided into net income. Diluted net income per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock. Stock options, unvested restricted shares, unvested performance share units and unvested restricted share units are included as potential dilutive securities for the periods applicable, using the treasury stock method to the extent dilutive. The components of the calculation of basic net income per common share and diluted net income per common share are as follows (in thousands except share and per share data): Three Months Ended Nine Months Ended September 24, 2016 September 26, 2015 September 24, 2016 September 26, 2015 Numerator: Net income $ 11,363 $ 14,098 $ 36,578 $ 47,039 Denominator: Basic weighted average common shares outstanding 23,578,334 28,988,779 24,048,201 29,238,808 Effect of dilutive securities: Stock options 67,797 86,627 70,837 103,885 Restricted shares 110,761 113,535 113,515 160,252 Performance share units 11,602 — 5,619 — Restricted share units 1,232 1,513 1,082 1,473 Diluted weighted average common shares outstanding 23,769,726 29,190,454 24,239,254 29,504,418 Basic net income per common share $ 0.48 $ 0.49 $ 1.52 $ 1.61 Diluted net income per common share $ 0.48 $ 0.48 $ 1.51 $ 1.59 Stock options, restricted shares and performance share units for the three months ended September 24, 2016 and September 26, 2015 in the amount of 35,106 shares and 90,737 shares, respectively, have been excluded from the above calculation as they were anti-dilutive. Stock options, restricted shares and performance share units for the nine months ended September 24, 2016 and September 26, 2015 in the amount of 15,088 shares and 34,803 shares, respectively, have been excluded from the above calculation as they were anti-dilutive. The Company has the intent and ability to settle the principal portion of its Convertible Notes in cash, and as such, has applied the treasury stock method, which has resulted in the underlying convertible shares being anti-dilutive for the three and nine months ended September 24, 2016 as the Company’s average stock price was less than the conversion price. Refer to Note 5. Credit Arrangements for additional information on the Convertible Notes.

Share Repurchase Programs

Share Repurchase Programs	9 Months Ended
	Sep. 24, 2016
Equity [Abstract]
Share Repurchase Programs	Share Repurchase Programs The Company’s board of directors approved share repurchase programs that enable the Company to purchase up to an aggregate of $300 million of its shares of common stock from time to time over three year periods ending on August 4, 2017 , May 5, 2018 and November 22, 2018 , respectively. As of September 24, 2016 , 7,665,954 shares have been repurchased for a total of $259.9 million . The repurchase program does not obligate the Company to acquire any specific number of shares of its common stock and may be suspended, terminated or modified at any time for any reason, including market conditions, the cost of repurchasing such shares, the availability of alternative investment opportunities, liquidity, and other factors deemed appropriate. These factors may also affect the timing and amount of share repurchases. During the three and nine months ended September 24, 2016 , the Company repurchased 179,648 and 1,919,132 shares, respectively, which were retired upon repurchase. The total purchase price during the three and nine months ended September 24, 2016 was $5.0 million and $56.0 million , respectively, with an average repurchase price per share of $27.83 and $29.19 , respectively. During the three and nine months ended September 26, 2015 , the Company repurchased 355,021 and 981,353 shares, respectively, which were retired upon repurchase. The total purchase price during the three and nine months ended September 26, 2015 was $12.4 million and $38.0 million , respectively, with an average repurchase price per share of $35.00 and $38.69 , respectively.

Legal Proceedings

Legal Proceedings	9 Months Ended
	Sep. 24, 2016
Commitments and Contingencies Disclosure [Abstract]
Legal Proceedings	Legal Proceedings The Company is party to various lawsuits arising from time to time in the normal course of business, some of which are covered by insurance. Although the impact of the final resolution of these matters on the Company's financial condition, results of operations or cash flows is not known, management does not believe that the resolution of these lawsuits will have a material adverse effect on the financial condition, results of operations or liquidity of the Company.

Segment Data

Segment Data	9 Months Ended
	Sep. 24, 2016
Segment Reporting [Abstract]
Segment Data	Segment Data The Company currently operates three business segments, retail, direct and manufacturing. The operating segments are segments of the Company for which separate financial information is available and for which operating results are evaluated regularly by executive management in deciding how to allocate resources and in assessing performance. The Company's management evaluates segment operating results based on several indicators. The primary key performance indicators are sales and operating income for each segment. The table below represents key financial information for each of the Company's business segments as well as corporate costs. The retail segment primarily includes the Company's retail stores. The retail segment generates revenue primarily through the sale of VMS products through Vitamin Shoppe and Super Supplements retail stores in the United States and Puerto Rico. The direct segment generates revenue through the sale of VMS products primarily through the Company's websites. The Company's websites offer customers online access to a full assortment of approximately 17,000 SKUs. The manufacturing segment supplies the retail and direct segments, along with various third parties, with finished products for sale. Corporate costs represent all other expenses not allocated to the retail, direct or manufacturing segments which include, but are not limited to: human resources, legal, retail management, direct management, finance, information technology, depreciation (primarily related to assets utilized by the retail and direct business segments as well as corporate assets) and amortization, and various other corporate level activity related expenses. Intercompany sales transactions are eliminated in consolidation. The Company’s segments are designed to allocate resources internally and provide a framework to determine management responsibility. The accounting policies of the segments are consistent with those described in Note 2. Summary of Significant Accounting Policies in the Fiscal 2015 Form 10-K. The Company has allocated $165.3 million , $45.3 million and $32.6 million of its recorded goodwill to the retail, direct and manufacturing segments, respectively. The Company does not have identifiable assets separated by segment, with the exception of the identifiable assets of the manufacturing segment which were $89.9 million and $88.4 million as of September 24, 2016 and December 26, 2015, respectively. Capital expenditures for the manufacturing segment for the nine months ended September 24, 2016 and September 26, 2015 were approximately $1.9 million and $3.0 million , respectively. At September 24, 2016 and December 26, 2015 , long lived assets of the manufacturing segment were $59.5 million and $60.4 million , respectively. Depreciation and amortization expense, included in selling, general and administrative expenses, for the manufacturing segment during the three months ended September 24, 2016 and September 26, 2015 was approximately $0.5 million and $0.4 million , respectively. Depreciation and amortization expense, included in selling, general and administrative expenses, for the manufacturing segment during the nine months ended September 24, 2016 and September 26, 2015 was approximately $1.4 million and $1.1 million , respectively. The following table contains key financial information of the Company’s business segments (in thousands): Three Months Ended Nine Months Ended September 24, 2016 September 26, 2015 September 24, 2016 September 26, 2015 Net sales: Retail $ 270,756 $ 270,213 $ 847,058 $ 836,396 Direct 30,321 31,254 98,946 96,444 Manufacturing 24,357 20,693 65,695 67,185 Segment net sales 325,434 322,160 1,011,699 1,000,025 Elimination of intersegment revenues (10,547 ) (8,274 ) (27,321 ) (26,966 ) Net sales $ 314,887 $ 313,886 $ 984,378 $ 973,059 Income (Loss) from operations: Retail $ 45,397 $ 47,890 $ 152,529 $ 155,562 Direct 4,498 5,324 14,184 15,976 Manufacturing (1) (734 ) (222 ) (2,818 ) (1,433 ) Corporate costs (2) (28,888 ) (29,635 ) (95,636 ) (92,229 ) Income from operations $ 20,273 $ 23,357 $ 68,259 $ 77,876 (1) Manufacturing loss from operations for the nine months ended September 26, 2015 includes a $1.4 million charge for accounts receivable for one wholesale customer which were deemed uncollectible. (2) Corporate costs include (in thousands): Three Months Ended Nine Months Ended September 24, 2016 September 26, 2015 September 24, 2016 September 26, 2015 Depreciation and amortization expenses $ 8,828 $ 9,323 $ 27,462 $ 27,359 Canada stores closing costs (a) (906 ) — 2,057 — Cost reduction project (b) 2,269 — 3,761 — Super Supplements conversion costs (c) — — 1,275 — Reinvention strategy costs (d) — 1,026 541 1,026 Management realignment charges (e) — — — 2,174 Integration costs (f) — 617 — 1,387 (a) Charges primarily related to lease terminations. The credit during the three months ended September 24, 2016 relates to a reversal of lease liabilities previously accrued. (b) Outside consulting costs relating to a project to identify and implement cost reduction opportunities. (c) Costs primarily related to the closure of the Seattle distribution center. (d) The costs represent outside consultants fees in connection with the Company’s “reinvention strategy”. (e) Management realignment charges primarily consist of severance, sign-on bonuses, recruiting and relocation costs. (f) Represents integration costs related to the acquisition of Nutri-Force, consisting primarily of professional fees.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 24, 2016
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value hierarchy requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. The three levels are defined as follows: • Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities. • Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. • Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability. The Company’s financial instruments include cash, accounts receivable, accounts payable and its Revolving Credit Facility. The Company believes that the recorded values of these financial instruments approximate their fair values due to their nature and respective durations. The Company's financial instruments also include its Convertible Notes (in thousands): September 24, 2016 December 26, 2015 Fair Value $ 113,669 $ 119,784 Carrying Value 119,413 115,410 The fair value of the Convertible Notes was determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including the trading price of the Company’s Convertible Notes, when available, the Company’s stock price and interest rates based on similar debt issued by parties with credit ratings similar to the Company (Level 1 or 2). Certain assets are measured at fair value on a non-recurring basis, that is, the assets are subject to fair value adjustments in certain circumstances such as when there is evidence of impairment. These measures of fair value, and related inputs, are considered Level 2 or 3 measures under the fair value hierarchy.

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Sep. 24, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Use of Estimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements, and revenue and expenses during the reporting period. Actual results could differ from those estimates.
New Accounting Pronouncements	Except as noted below, the Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on its results of operations, financial condition, or cash flows, based on current information. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09 (“ASU 2014-09”), Revenue from Contracts with Customers (Topic 606). Under ASU 2014-09, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of ASU 2014-09 by one year. ASU 2014-09 will be effective for annual reporting periods beginning after December 15, 2017 for public companies and early adoption of ASU 2014-09 is permitted for public companies for annual reporting periods beginning after December 15, 2016. The Company is evaluating ASU 2014-09 to determine which transition approach it will utilize and if this guidance will have a material impact on the Company’s condensed consolidated financial statements. In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (“ASU 2016-02”), Leases (Topic 842). ASU 2016-02 was issued by the FASB to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. ASU 2016-02 will require modified retrospective application at the beginning of our first quarter of Fiscal 2019, but permits adoption in an earlier period. The Company is evaluating ASU 2016-02 in order to determine the impact of this guidance on the Company’s condensed consolidated financial statements and anticipates this guidance will result in a significant increase to long-term assets and liabilities given we have a significant number of leases. In March 2016, the FASB issued Accounting Standards Update No. 2016-09 (“ASU 2016-09”), Compensation-Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 addresses simplification of several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for public companies for annual reporting periods beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption of ASU 2016-09 is permitted. The Company has evaluated ASU 2016-09 and does not expect the impact of this guidance to have a material impact on the Company's condensed consolidated financial statements. However, under certain circumstances, this guidance could have an impact on the Company’s effective tax rate as changes between tax and book treatment of equity compensation will be recognized in the provision for income taxes beginning in Fiscal 2017.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 24, 2016
Inventory Disclosure [Abstract]
Components of Inventories	The components of inventories are as follows (in thousands): September 24, 2016 December 26, 2015 Finished goods $ 202,202 $ 211,879 Work-in-process 5,016 6,180 Raw materials 16,454 8,771 $ 223,672 $ 226,830

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 24, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table discloses the carrying value of all intangible assets (in thousands): September 24, 2016 December 26, 2015 Gross Carrying Amount Accumulated Amortization Net Gross Carrying Amount Accumulated Amortization Net Intangible assets Goodwill $ 243,269 $ — $ 243,269 $ 243,269 $ — $ 243,269 Tradenames – Indefinite-lived 68,405 — 68,405 68,405 — 68,405 Brands 10,000 1,296 8,704 10,000 880 9,120 Customer relationships 7,500 875 6,625 7,500 594 6,906 Tradenames – Definite-lived 4,894 3,007 1,887 4,673 2,722 1,951 Software 1,300 607 693 1,300 412 888 $ 335,368 $ 5,785 $ 329,583 $ 335,147 $ 4,608 $ 330,539
Expected Amortization Expense on Definite-Lived Intangible Assets	The expected amortization expense on definite-lived intangible assets on the Company’s condensed consolidated balance sheet at September 24, 2016 , is as follows (in thousands): Remainder of Fiscal 2016 $ 355 Fiscal 2017 1,435 Fiscal 2018 1,435 Fiscal 2019 1,435 Fiscal 2020 1,435 Thereafter 11,814 $ 17,909

Accrued Expenses and Other Cu22

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 24, 2016
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consist of the following (in thousands): September 24, 2016 December 26, 2015 Accrued salaries and related expenses $ 14,124 $ 10,115 Sales tax payable and related expenses 7,777 6,975 Deferred sales (a) 5,413 20,483 Accrued fixed asset additions 3,935 5,842 Other accrued expenses 28,888 24,844 $ 60,137 $ 68,259 (a) The reduction in deferred sales reflects the change in the Company's loyalty program from annual redemptions to quarterly redemptions beginning in Fiscal 2016.

Credit Arrangements (Tables)

Credit Arrangements (Tables)	9 Months Ended
	Sep. 24, 2016
Debt Disclosure [Abstract]
Components of Convertible Notes	The Convertible Notes consist of the following components (in thousands): September 24, 2016 December 26, 2015 Liability component: Principal $ 143,750 $ 143,750 Conversion feature (24,800 ) (24,800 ) Liability portion of debt issuance costs (3,802 ) (3,800 ) Amortization 4,265 260 Net carrying amount $ 119,413 $ 115,410 Equity component: Conversion feature $ 24,800 $ 24,800 Equity portion of debt issuance costs (793 ) (793 ) Deferred taxes 941 941 Net carrying amount $ 24,948 $ 24,948
Interest Expense, Net	Interest expense, net for the three and nine months ended September 24, 2016 and September 26, 2015 consists of the following (in thousands): Three Months Ended Nine Months Ended September 24, 2016 September 26, 2015 September 24, 2016 September 26, 2015 Amortization of debt discount on convertible notes $ 1,156 $ — $ 3,434 $ — Interest on convertible notes 818 — 2,455 — Amortization of deferred financing fees 236 62 708 141 Interest / fees on the revolving credit facility and other interest 153 110 380 375 Interest income — — — (1 ) Interest expense, net $ 2,363 $ 172 $ 6,977 $ 515

Stock Based Compensation (Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 24, 2016
Summary of Stock Options	The following table summarizes stock options for the 2006 and 2009 Plans as of September 24, 2016 and changes during the nine month period then ended: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life (years) Aggregate Intrinsic Value (in thousands) Outstanding at December 26, 2015 284,838 $ 22.65 Granted 233,285 $ 30.03 Exercised (5,282 ) $ 17.11 Canceled/forfeited (30,155 ) $ 32.66 Outstanding at September 24, 2016 482,686 $ 25.65 5.38 $ 2,022 Vested or expected to vest at September 24, 2016 467,286 $ 25.65 5.38 Vested and exercisable at September 24, 2016 261,449 $ 21.95 1.89 $ 2,020
Summary of Performance Share Units	The following table summarizes performance share units for the 2009 Plan as of September 24, 2016 and changes during the nine month period then ended: Number of Unvested Performance Share Units Weighted Average Grant Date Fair Value Unvested at December 26, 2015 — $ — Granted 134,927 $ 30.42 Vested — $ — Canceled/forfeited (6,608 ) $ 30.26 Unvested at September 24, 2016 128,319 $ 30.43
Summary of Fair Value Option Grant Using Black-Scholes Option-Pricing Model	The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions: Three Months Ended Nine Months Ended September 24, 2016 September 24, 2016 Expected dividend yield 0.0 % 0.0 % Weighted average expected volatility 31.4 % 32.5 % Weighted average risk-free interest rate 1.0 % 1.2 % Expected holding period 4.00 years 4.00 years
Restricted Shares [Member]
Summary of Restricted Shares and Restricted Share Units	The following table summarizes restricted shares for the 2009 Plan as of September 24, 2016 and changes during the nine month period then ended: Number of Unvested Restricted Shares Weighted Average Grant Date Fair Value Unvested at December 26, 2015 398,562 $ 42.65 Granted 165,605 $ 30.04 Vested (101,009 ) $ 46.72 Canceled/forfeited (84,031 ) $ 43.35 Unvested at September 24, 2016 379,127 $ 35.90
Restricted Share Units [Member]
Summary of Restricted Shares and Restricted Share Units	The following table summarizes restricted share units for the 2009 Plan as of September 24, 2016 and changes during the nine month period then ended: Number of Unvested Weighted Unvested at December 26, 2015 11,280 $ 37.25 Granted 21,451 $ 30.68 Vested (12,220 ) $ 36.69 Canceled/forfeited — $ — Unvested at September 24, 2016 20,511 $ 30.71

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
	Sep. 24, 2016
Earnings Per Share [Abstract]
Calculation of Basic and Diluted Net Income Per Common Share	The components of the calculation of basic net income per common share and diluted net income per common share are as follows (in thousands except share and per share data): Three Months Ended Nine Months Ended September 24, 2016 September 26, 2015 September 24, 2016 September 26, 2015 Numerator: Net income $ 11,363 $ 14,098 $ 36,578 $ 47,039 Denominator: Basic weighted average common shares outstanding 23,578,334 28,988,779 24,048,201 29,238,808 Effect of dilutive securities: Stock options 67,797 86,627 70,837 103,885 Restricted shares 110,761 113,535 113,515 160,252 Performance share units 11,602 — 5,619 — Restricted share units 1,232 1,513 1,082 1,473 Diluted weighted average common shares outstanding 23,769,726 29,190,454 24,239,254 29,504,418 Basic net income per common share $ 0.48 $ 0.49 $ 1.52 $ 1.61 Diluted net income per common share $ 0.48 $ 0.48 $ 1.51 $ 1.59

Segment Data (Tables)

Segment Data (Tables)	9 Months Ended
	Sep. 24, 2016
Segment Reporting [Abstract]
Table of Key Financial Information of Company's Business Segments	The following table contains key financial information of the Company’s business segments (in thousands): Three Months Ended Nine Months Ended September 24, 2016 September 26, 2015 September 24, 2016 September 26, 2015 Net sales: Retail $ 270,756 $ 270,213 $ 847,058 $ 836,396 Direct 30,321 31,254 98,946 96,444 Manufacturing 24,357 20,693 65,695 67,185 Segment net sales 325,434 322,160 1,011,699 1,000,025 Elimination of intersegment revenues (10,547 ) (8,274 ) (27,321 ) (26,966 ) Net sales $ 314,887 $ 313,886 $ 984,378 $ 973,059 Income (Loss) from operations: Retail $ 45,397 $ 47,890 $ 152,529 $ 155,562 Direct 4,498 5,324 14,184 15,976 Manufacturing (1) (734 ) (222 ) (2,818 ) (1,433 ) Corporate costs (2) (28,888 ) (29,635 ) (95,636 ) (92,229 ) Income from operations $ 20,273 $ 23,357 $ 68,259 $ 77,876 (1) Manufacturing loss from operations for the nine months ended September 26, 2015 includes a $1.4 million charge for accounts receivable for one wholesale customer which were deemed uncollectible. (2) Corporate costs include (in thousands): Three Months Ended Nine Months Ended September 24, 2016 September 26, 2015 September 24, 2016 September 26, 2015 Depreciation and amortization expenses $ 8,828 $ 9,323 $ 27,462 $ 27,359 Canada stores closing costs (a) (906 ) — 2,057 — Cost reduction project (b) 2,269 — 3,761 — Super Supplements conversion costs (c) — — 1,275 — Reinvention strategy costs (d) — 1,026 541 1,026 Management realignment charges (e) — — — 2,174 Integration costs (f) — 617 — 1,387 (a) Charges primarily related to lease terminations. The credit during the three months ended September 24, 2016 relates to a reversal of lease liabilities previously accrued. (b) Outside consulting costs relating to a project to identify and implement cost reduction opportunities. (c) Costs primarily related to the closure of the Seattle distribution center. (d) The costs represent outside consultants fees in connection with the Company’s “reinvention strategy”. (e) Management realignment charges primarily consist of severance, sign-on bonuses, recruiting and relocation costs. (f) Represents integration costs related to the acquisition of Nutri-Force, consisting primarily of professional fees.

Fair Value of Financial Instr27

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 24, 2016
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Convertible Notes	The Company's financial instruments also include its Convertible Notes (in thousands): September 24, 2016 December 26, 2015 Fair Value $ 113,669 $ 119,784 Carrying Value 119,413 115,410

Inventories - Components of Inv

Inventories - Components of Inventories (Detail) - USD ($) $ in Thousands	Sep. 24, 2016	Dec. 26, 2015
Inventory Disclosure [Abstract]
Finished goods	$ 202,202	$ 211,879
Work-in-process	5,016	6,180
Raw materials	16,454	8,771
Total inventories	$ 223,672	$ 226,830

Goodwill and Intangible Asset29

Goodwill and Intangible Assets - Schedule of Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 24, 2016	Dec. 26, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill, Gross Carrying Amount	$ 243,269	$ 243,269
Goodwill, Net	243,269	243,269
Finite-Lived Intangible Assets [Line Items]
Intangible assets, Accumulated Amortization	5,785	4,608
Intangible assets, Definite-lived, Net	17,909
Intangible Assets, Net (Including Goodwill) [Abstract]
Goodwill and Intangible Assets, Gross Carrying Amount	335,368	335,147
Goodwill and Intangible Assets, Net	329,583	330,539
Tradenames [Member]
Indefinite-lived Intangible Assets [Line Items]
Intangible assets, Tradenames - Indefinite-lived, Gross Carrying Amount	68,405	68,405
Intangible assets, Tradenames - Indefinite-lived, Net	68,405	68,405
Brands [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, Definite-lived, Gross Carrying Amount	10,000	10,000
Intangible assets, Accumulated Amortization	1,296	880
Intangible assets, Definite-lived, Net	8,704	9,120
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, Definite-lived, Gross Carrying Amount	7,500	7,500
Intangible assets, Accumulated Amortization	875	594
Intangible assets, Definite-lived, Net	6,625	6,906
Tradenames [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, Definite-lived, Gross Carrying Amount	4,894	4,673
Intangible assets, Accumulated Amortization	3,007	2,722
Intangible assets, Definite-lived, Net	1,887	1,951
Software [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, Definite-lived, Gross Carrying Amount	1,300	1,300
Intangible assets, Accumulated Amortization	607	412
Intangible assets, Definite-lived, Net	$ 693	$ 888

Goodwill and Intangible Asset30

Goodwill and Intangible Assets - Additional Information (Detail)	9 Months Ended
	Sep. 24, 2016
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful lives of definite-lived intangible assets, years	3 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful lives of definite-lived intangible assets, years	20 years

Goodwill and Intangible Asset31

Goodwill and Intangible Assets - Expected Amortization Expense on Definite-Lived Intangible Assets (Detail) $ in Thousands	Sep. 24, 2016USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of Fiscal 2016	$ 355
Fiscal 2,017	1,435
Fiscal 2,018	1,435
Fiscal 2,019	1,435
Fiscal 2,020	1,435
Thereafter	11,814
Intangible assets, Definite-lived, Net	$ 17,909

Accrued Expenses and Other Cu32

Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands	Sep. 24, 2016	Dec. 26, 2015
Payables and Accruals [Abstract]
Accrued salaries and related expenses	$ 14,124	$ 10,115
Sales tax payable and related expenses	7,777	6,975
Deferred sales	5,413	20,483
Accrued fixed asset additions	3,935	5,842
Other accrued expenses	28,888	24,844
Accrued expenses and other current liabilities	$ 60,137	$ 68,259

Credit Arrangements - Additiona

Credit Arrangements - Additional Information (Detail) - USD ($)	Dec. 09, 2015	Sep. 24, 2016	Dec. 26, 2015	Sep. 26, 2015
Debt Instrument [Line Items]
Outstanding debt		$ 6,000,000	$ 8,000,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Outstanding debt		$ 6,000,000	$ 8,000,000
Revolving Credit Facility, maturity date		Oct. 11, 2018
Revolving Credit Facility, current borrowing capacity		$ 90,000,000
Revolving Credit Facility, maximum borrowing capacity		150,000,000
Maximum borrowings under Revolving Credit Facility		27,000,000		$ 27,000,000
Revolving Credit Facility, unused available line of credit		$ 81,100,000
Revolving Credit Facility, interest rate description		Borrowings under the Revolving Credit Facility
Percentage of aggregate borrowings facility limit		50.00%
Weighted average interest rate		1.75%		1.44%
Percentage of commitment fee on undrawn portion of Revolving Credit Facility		0.25%	0.25%
Revolving Credit Facility [Member] | Alternative Base Rate [Member] | Minimum [Member]
Debt Instrument [Line Items]
Variable interest rate, basis spread		0.25%
Revolving Credit Facility [Member] | Alternative Base Rate [Member] | Maximum [Member]
Debt Instrument [Line Items]
Variable interest rate, basis spread		0.50%
Revolving Credit Facility [Member] | Adjusted Eurodollar Rate [Member] | Minimum [Member]
Debt Instrument [Line Items]
Variable interest rate, basis spread		1.25%
Revolving Credit Facility [Member] | Adjusted Eurodollar Rate [Member] | Maximum [Member]
Debt Instrument [Line Items]
Variable interest rate, basis spread		1.50%
Convertible Senior Notes Due 2020 [Member]
Debt Instrument [Line Items]
Principal	$ 143,800,000	$ 143,750,000	$ 143,750,000
Debt instrument, interest rate	2.25%
Debt converted into shares of common stock (in shares)	25.1625
Debt instrument, conversion price	$ 1,000
Stock, initial conversion price per share (in dollars per share)	$ 39.74
Debt instrument, effective interest rate on debt discount	3.80%
Convertible note hedge transactions amount paid	$ 26,400,000
Proceeds from sale of warrants	$ 13,000,000
Strike price of warrant (in dollars per share)	$ 52.99
Net proceeds from Convertible Notes and related transactions	$ 125,700,000
Commissions and offering costs	$ 4,600,000

Credit Arrangements - Component

Credit Arrangements - Components of Convertible Notes (Details) - USD ($)	Sep. 24, 2016	Dec. 26, 2015	Dec. 09, 2015
Liability component:
Convertible notes, net	$ 119,413,000	$ 115,410,000
Convertible Senior Notes Due 2020 [Member]
Liability component:
Principal	143,750,000	143,750,000	$ 143,800,000
Conversion feature	(24,800,000)	(24,800,000)
Liability portion of debt issuance costs	(3,802,000)	(3,800,000)
Amortization	4,265,000	260,000
Convertible notes, net	119,413,000	115,410,000
Equity component:
Conversion feature	24,800,000	24,800,000
Equity portion of debt issuance costs	(793,000)	(793,000)
Deferred taxes	941,000	941,000
Net carrying amount	$ 24,948,000	$ 24,948,000

Credit Arrangements - Interest

Credit Arrangements - Interest Expense, Net (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 24, 2016	Sep. 26, 2015	Sep. 24, 2016	Sep. 26, 2015
Debt Instrument [Line Items]
Amortization of debt discount on convertible notes			$ 3,434	$ 0
Amortization of deferred financing fees	$ 236	$ 62	708	141
Interest income	0	0	0	(1)
Interest expense, net	2,363	172	6,977	515
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest / fees on convertible notes, revolving credit facility, and other interest	153	110	380	375
Convertible Senior Notes Due 2020 [Member]
Debt Instrument [Line Items]
Amortization of debt discount on convertible notes	1,156	0	3,434	0
Interest / fees on convertible notes, revolving credit facility, and other interest	$ 818	$ 0	$ 2,455	$ 0

Stock Based Compensation - Addi

Stock Based Compensation - Additional Information (Detail) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 24, 2016USD ($)$ / sharesshares	Sep. 26, 2015USD ($)	Sep. 24, 2016USD ($)Plan$ / sharesshares	Sep. 26, 2015USD ($)	Dec. 26, 2015shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans | Plan			2
Treasury stock (in shares) | shares	160,010		160,010		120,134
Intrinsic value of options exercised			$ 0.1	$ 1
Cash received from options exercised			0.1	1.3
Compensation expense attributable to stock based compensation	$ 1.2	$ 1.2	4.7	4.7
Remaining unrecognized stock based compensation expense for non-vested stock options, restricted shares and restricted shares units to be expensed in future periods	8.9		$ 8.9
Weighted average recognition period for non-vested stock options, restricted shares and restricted shares units			1 year 9 months 18 days
Estimated value of future forfeitures for stock options, restricted shares and restricted share units	$ 0.7		$ 0.7
Weighted-average grant date fair value for stock options (in dollars per share) | $ / shares	$ 7.07		$ 8.21
Treasury stock purchased in settlement of employees' tax obligations (in shares) | shares			39,876
Treasury stock purchased in settlement of employees' tax obligations, value			$ 1.2
2006 and 2009 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available to grant under both plans (in shares) | shares	2,077,482		2,077,482
Restricted Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of shares vested			$ 2.7	6.2
Performance Share Units [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			25.00%
Performance Share Units [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			150.00%
Restricted Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of shares vested			$ 0.3	$ 0.5

Stock Based Compensation - Summ

Stock Based Compensation - Summary of Restricted Shares, Performance Share Units, and Restricted Share Units (Detail)	9 Months Ended
	Sep. 24, 2016$ / sharesshares
Restricted Shares [Member]
Number of Unvested Shares
Unvested at December 26, 2015 (in shares) | shares	398,562
Granted (in shares) | shares	165,605
Vested (in shares) | shares	(101,009)
Canceled/forfeited (in shares) | shares	(84,031)
Unvested at September 24, 2016 (in shares) | shares	379,127
Weighted Average Grant Date Fair Value
Unvested at December 26, 2015 (in dollars per share) | $ / shares	$ 42.65
Granted (in dollars per share) | $ / shares	30.04
Vested (in dollars per share) | $ / shares	46.72
Canceled/forfeited (in dollars per share) | $ / shares	43.35
Unvested at September 24, 2016 (in dollars per share) | $ / shares	$ 35.90
Performance Share Units [Member]
Number of Unvested Shares
Unvested at December 26, 2015 (in shares) | shares	0
Granted (in shares) | shares	134,927
Vested (in shares) | shares	0
Canceled/forfeited (in shares) | shares	(6,608)
Unvested at September 24, 2016 (in shares) | shares	128,319
Weighted Average Grant Date Fair Value
Unvested at December 26, 2015 (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	30.42
Vested (in dollars per share) | $ / shares	0
Canceled/forfeited (in dollars per share) | $ / shares	30.26
Unvested at September 24, 2016 (in dollars per share) | $ / shares	$ 30.43
Restricted Share Units [Member]
Number of Unvested Shares
Unvested at December 26, 2015 (in shares) | shares	11,280
Granted (in shares) | shares	21,451
Vested (in shares) | shares	(12,220)
Canceled/forfeited (in shares) | shares	0
Unvested at September 24, 2016 (in shares) | shares	20,511
Weighted Average Grant Date Fair Value
Unvested at December 26, 2015 (in dollars per share) | $ / shares	$ 37.25
Granted (in dollars per share) | $ / shares	30.68
Vested (in dollars per share) | $ / shares	36.69
Canceled/forfeited (in dollars per share) | $ / shares	0
Unvested at September 24, 2016 (in dollars per share) | $ / shares	$ 30.71

Stock Based Compensation - Su38

Stock Based Compensation - Summary of Stock Options (Detail) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 24, 2016USD ($)$ / sharesshares
Number of Options
Outstanding at December 26, 2015, Number of Options (in shares) | shares	284,838
Granted, Number of Options (in shares) | shares	233,285
Exercised, Number of Options (in shares) | shares	(5,282)
Canceled/forfeited, Number of Options (in shares) | shares	(30,155)
Outstanding at September 24, 2016, Number of Options (in shares) | shares	482,686
Vested or expected to vest at September 24, 2016, Number of Options (in shares) | shares	467,286
Vested and exercisable at September 24, 2016, Number of Options (in shares) | shares	261,449
Weighted Average Exercise Price
Outstanding at December 26, 2015, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 22.65
Granted, Weighted Average Exercise Price (in dollars per share) | $ / shares	30.03
Exercised, Weighted Average Exercise Price (in dollars per share) | $ / shares	17.11
Canceled/forfeited, Weighted Average Exercise Price (in dollars per share) | $ / shares	32.66
Outstanding at September 24, 2016, Weighted Average Exercise Price (in dollars per share) | $ / shares	25.65
Vested or expected to vest at September 24, 2016, Weighted Average Exercise Price (in dollars per share) | $ / shares	25.65
Vested and exercisable at September 24, 2016, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 21.95
Outstanding at September 24, 2016, Weighted Average Remaining Contractual Life (years)	5 years 4 months 17 days
Vested or expected to vest at September 24, 2016, Weighted Average Remaining Contractual Life (years)	5 years 4 months 17 days
Vested and exercisable at September 24, 2016, Weighted Average Remaining Contractual Life (years)	1 year 10 months 21 days
Outstanding at September 24, 2016, Aggregate Intrinsic Value | $	$ 2,022
Vested and exercisable at September 24, 2016, Aggregate Intrinsic Value | $	$ 2,020

Stock Based Compensation - Su39

Stock Based Compensation - Summary of Fair Value Option Grant Using Black-Scholes Option-Pricing Model (Detail)	3 Months Ended	9 Months Ended
	Sep. 24, 2016	Sep. 24, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Expected dividend yield	0.00%	0.00%
Weighted average expected volatility	31.40%	32.50%
Weighted average risk-free interest rate	1.00%	1.20%
Expected holding period	4 years	4 years

Advertising Costs - Additional

Advertising Costs - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 24, 2016	Sep. 26, 2015	Sep. 24, 2016	Sep. 26, 2015
Other Income and Expenses [Abstract]
Advertising expense	$ 5.7	$ 5.3	$ 18.1	$ 16.8

Net Income Per Share - Calculat

Net Income Per Share - Calculation of Basic and Diluted Net Income Per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 24, 2016	Sep. 26, 2015	Sep. 24, 2016	Sep. 26, 2015
Summary Of Computation Of Basic And Diluted Earnings Per Share [Line Items]
Net income	$ 11,363	$ 14,098	$ 36,578	$ 47,039
Basic weighted average common shares outstanding (in shares)	23,578,334	28,988,779	24,048,201	29,238,808
Diluted weighted average common shares outstanding (in shares)	23,769,726	29,190,454	24,239,254	29,504,418
Basic net income per common share (in dollars per share)	$ 0.48	$ 0.49	$ 1.52	$ 1.61
Diluted net income per common share (in dollars per share)	$ 0.48	$ 0.48	$ 1.51	$ 1.59
Stock Options [Member]
Summary Of Computation Of Basic And Diluted Earnings Per Share [Line Items]
Effect of dilutive securities (in shares)	67,797	86,627	70,837	103,885
Restricted Shares [Member]
Summary Of Computation Of Basic And Diluted Earnings Per Share [Line Items]
Effect of dilutive securities (in shares)	110,761	113,535	113,515	160,252
Performance Share Units [Member]
Summary Of Computation Of Basic And Diluted Earnings Per Share [Line Items]
Effect of dilutive securities (in shares)	11,602	0	5,619	0
Restricted Share Units [Member]
Summary Of Computation Of Basic And Diluted Earnings Per Share [Line Items]
Effect of dilutive securities (in shares)	1,232	1,513	1,082	1,473

Net Income Per Share - Addition

Net Income Per Share - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 24, 2016	Sep. 26, 2015	Sep. 24, 2016	Sep. 26, 2015
Stock Options, Restricted Shares and Performance Share Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of earnings per share (in shares)	35,106	90,737	15,088	34,803

Share Repurchase Programs - Add

Share Repurchase Programs - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 24, 2016	Sep. 26, 2015	Sep. 24, 2016	Sep. 26, 2015
Equity [Abstract]
Purchase of common stock under share repurchase programs	$ 300,000,000		$ 300,000,000
Stock repurchase program, period in force			3 years
Number of shares repurchased (in shares)	7,665,954		7,665,954
Total shares repurchased, value	$ 259,900,000		$ 259,900,000
Stock repurchased and retired during period (in shares)	179,648	355,021	1,919,132	981,353
Stock repurchased and retired during period, value	$ 5,000,000	$ 12,400,000	$ 56,000,000	$ 38,000,000
Common stock shares repurchased price per share (in dollars per share)	$ 27.83	$ 35	$ 29.19	$ 38.69

Segment Data - Additional Infor

Segment Data - Additional Information (Detail) Stock_Unit in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 24, 2016USD ($)	Sep. 26, 2015USD ($)	Sep. 24, 2016USD ($)Stock_UnitSegment	Sep. 26, 2015USD ($)	Dec. 26, 2015USD ($)
Segment Reporting Information [Line Items]
Number of business segments | Segment			3
Number of SKUs available for online access | Stock_Unit			17
Goodwill	$ 243,269		$ 243,269		$ 243,269
Identifiable assets	736,517		736,517		748,691
Capital expenditures			31,228	$ 30,172
Retail [Member]
Segment Reporting Information [Line Items]
Goodwill	165,300		165,300
Direct [Member]
Segment Reporting Information [Line Items]
Goodwill	45,300		45,300
Manufacturing [Member]
Segment Reporting Information [Line Items]
Goodwill	32,600		32,600
Identifiable assets	89,900		89,900		88,400
Capital expenditures			1,900	3,000
Long lived assets	59,500		59,500		$ 60,400
Depreciation and amortization expenses	$ 500	$ 400	$ 1,400	$ 1,100

Segment Data - Table of Key Fin

Segment Data - Table of Key Financial Information of Company's Business Segments (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 24, 2016USD ($)	Sep. 26, 2015USD ($)	Sep. 24, 2016USD ($)	Sep. 26, 2015USD ($)Customer
Revenue from External Customer [Line Items]
Net sales	$ 314,887	$ 313,886	$ 984,378	$ 973,059
Income (loss) from operations	20,273	23,357	68,259	77,876
Operating Segments [Member]
Revenue from External Customer [Line Items]
Net sales	325,434	322,160	1,011,699	1,000,025
Operating Segments [Member] | Retail [Member]
Revenue from External Customer [Line Items]
Net sales	270,756	270,213	847,058	836,396
Income (loss) from operations	45,397	47,890	152,529	155,562
Operating Segments [Member] | Direct [Member]
Revenue from External Customer [Line Items]
Net sales	30,321	31,254	98,946	96,444
Income (loss) from operations	4,498	5,324	14,184	15,976
Operating Segments [Member] | Manufacturing [Member]
Revenue from External Customer [Line Items]
Net sales	24,357	20,693	65,695	67,185
Income (loss) from operations	(734)	(222)	(2,818)	(1,433)
Operating Segments [Member] | Manufacturing [Member] | Accounts Receivable [Member]
Revenue from External Customer [Line Items]
Charge for accounts receivable deemed uncollectable				$ 1,400
Number of wholesale customers | Customer				1
Elimination of Intersegment Revenues [Member]
Revenue from External Customer [Line Items]
Net sales	(10,547)	(8,274)	(27,321)	$ (26,966)
Corporate Costs [Member]
Revenue from External Customer [Line Items]
Income (loss) from operations	$ (28,888)	$ (29,635)	$ (95,636)	$ (92,229)

Segment Data - Table of Key F46

Segment Data - Table of Key Financial Information of Company's Business Segments , Components of Corporate Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 24, 2016	Sep. 26, 2015	Sep. 24, 2016	Sep. 26, 2015
Revenue from External Customer [Line Items]
Depreciation and amortization expenses			$ 28,812	$ 28,457
Corporate Costs [Member]
Revenue from External Customer [Line Items]
Depreciation and amortization expenses	$ 8,828	$ 9,323	27,462	27,359
Canada stores closing costs	(906)	0	2,057	0
Cost reduction project	2,269	0	3,761	0
Super Supplements conversion costs	0	0	1,275	0
Reinvention strategy costs	0	1,026	541	1,026
Management realignment charges	0	0	0	2,174
Corporate Costs [Member] | Nutri-Force [Member]
Revenue from External Customer [Line Items]
Integration costs	$ 0	$ 617	$ 0	$ 1,387

Fair Value of Financial Instr47

Fair Value of Financial Instruments - Schedule of Fair Value of Convertible Notes (Details) - Convertible Notes [Member] - USD ($) $ in Thousands	Sep. 24, 2016	Dec. 26, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 113,669	$ 119,784
Carrying Value	$ 119,413	$ 115,410